Article Details

Aerie Pharmaceuticals (NASDAQ:AERI) & Vir Biotechnology (NASDAQ:VIR) Head to Head Contrast

Retrieved on: 2022-07-18 12:19:43

Tags for this article:

Click the tags to see associated articles and topics

Aerie Pharmaceuticals (NASDAQ:AERI) & Vir Biotechnology (NASDAQ:VIR) Head to Head Contrast. View article details on hiswai:

Excerpt

Comparatively, Vir Biotechnology has a beta of -0.45, meaning that its stock price is 145% less volatile than the S&P 500. Get Aerie Pharmaceuticals ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up